Company Description
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.
The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care.
It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services.
Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services.
The company sells its products through field sales professionals, channel partners, and value-added resellers.
It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
| Country | United States |
| Founded | 2006 |
| IPO Date | Sep 17, 2020 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 562 |
| CEO | Ido Schoenberg |
Contact Details
Address: 75 State Street, 26th Floor Boston, Massachusetts 02109 United States | |
| Phone | 617 204 3500 |
| Website | business.amwell.com |
Stock Details
| Ticker Symbol | AMWL |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 1393584 |
| CUSIP Number | 03044L204 |
| ISIN Number | US03044L2043 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ido Schoenberg M.D. | Chairman and Chief Executive Officer |
| Dr. Roy Schoenberg M.D., M.P.H. | Executive Vice Chairman |
| Mark J. Hirschhorn CPA | Executive Vice President, Chief Operating Officer and Chief Financial Officer |
| Phyllis I. Gotlib | President of Amwell International |
| Paul Francis McNeice | Vice President of Accounting |
| Dan Zamansky | Chief Product and Technology Officer |
| Sue Dooley | Head of Investor Relations |
| Anna Nesterova | Head of Legal |
| Michael Miller | Senior Vice President and Chief Sales Officer |
| Dr. Cynthia Horner FAAFP, M.D. | Chief Medical Officer and President of Amwell Medical Group |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 2, 2026 | 144 | Filing |
| Mar 2, 2026 | 144 | Filing |
| Mar 2, 2026 | 144 | Filing |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Feb 12, 2026 | 10-K | Annual Report |
| Feb 12, 2026 | SCHEDULE 13G/A | Filing |
| Feb 12, 2026 | 8-K | Current Report |
| Jan 26, 2026 | SCHEDULE 13G | Filing |
| Jan 8, 2026 | 8-K | Current Report |
| Jan 2, 2026 | 8-K | Current Report |